Lexaria Bioscience Corp. (LEXX)
2.88
-0.21
(-6.80%)
USD |
NASDAQ |
Oct 02, 16:00
2.77
-0.11
(-3.82%)
After-Hours: 20:00
Lexaria Bioscience Market Cap : 4.759M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.759M |
| October 01, 2026 | 5.106M |
| September 30, 2026 | 5.205M |
| September 29, 2026 | 5.172M |
| September 28, 2026 | 5.329M |
| September 25, 2026 | 5.420M |
| September 24, 2026 | 5.569M |
| September 23, 2026 | 5.346M |
| September 22, 2026 | 5.321M |
| September 21, 2026 | 5.660M |
| September 18, 2026 | 5.354M |
| September 17, 2026 | 5.437M |
| September 16, 2026 | 5.114M |
| September 15, 2026 | 5.304M |
| September 14, 2026 | 5.866M |
| September 11, 2026 | 6.560M |
| September 10, 2026 | 6.693M |
| September 09, 2026 | 10.91M |
| September 08, 2026 | 15.48M |
| September 04, 2026 | 23.38M |
| September 03, 2026 | 20.36M |
| September 02, 2026 | 21.82M |
| September 01, 2026 | 20.61M |
| August 31, 2026 | 18.64M |
| August 28, 2026 | 17.10M |
| Date | Value |
|---|---|
| August 27, 2026 | 19.30M |
| August 26, 2026 | 18.24M |
| August 25, 2026 | 19.17M |
| August 24, 2026 | 17.42M |
| August 21, 2026 | 18.04M |
| August 20, 2026 | 18.62M |
| August 19, 2026 | 19.02M |
| August 18, 2026 | 19.04M |
| August 17, 2026 | 17.05M |
| August 14, 2026 | 14.94M |
| August 13, 2026 | 13.39M |
| August 12, 2026 | 10.11M |
| August 11, 2026 | 9.568M |
| August 10, 2026 | 9.072M |
| August 07, 2026 | 8.709M |
| August 06, 2026 | 8.824M |
| August 05, 2026 | 9.370M |
| August 04, 2026 | 9.287M |
| August 03, 2026 | 7.849M |
| July 31, 2026 | 9.692M |
| July 30, 2026 | 9.823M |
| July 29, 2026 | 13.14M |
| July 28, 2026 | 200.81M |
| July 27, 2026 | 193.90M |
| July 24, 2026 | 207.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Target Group, Inc. (Canada) | 0.4319M |
| InMed Pharmaceuticals, Inc. | 7.101M |
| XORTX Therapeutics, Inc. | 2.967M |
| NervGen Pharma Corp. | 189.41M |
| Milestone Pharmaceuticals, Inc. | 100.81M |
Market Cap Related Metrics
| PS Ratio | 22.31 |
| Price to Book Value | 1.004 |
| Price | 2.88 |
| Earnings Yield | -183.4% |